Brief: Urogen Pharma Reports Preliminary Jelmyto Sales For Q2

UroGen Pharma

14/07/2021 14:47

July 14 (Reuters) - Urogen Pharma Ltd  UR8.F :
    * UROGEN PHARMA REPORTS STRONG PRELIMINARY JELMYTO® SALES
FOR
SECOND QUARTER 2021
    * UROGEN PHARMA LTD - 73% GROWTH IN NET PRODUCT REVENUE OVER
1Q
2021 TO APPROXIMATELY $13.0 MILLION IN 2Q 2021
    * UROGEN PHARMA LTD - 2Q 2021 OPERATING EXPENSES ANTICIPATED
IN
RANGE OF $33 TO $38 MILLION

Source text for Eikon:  ID:nBw2Gkfpca 
Further company coverage:  UR8.F 

 ((Reuters.Briefs@thomsonreuters.com;))